CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 41 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,099,000 | +13.3% | 381,679 | +3.2% | 0.00% | – |
| Q3 2016 | $1,853,000 | +7.9% | 369,877 | -3.1% | 0.00% | – |
| Q2 2016 | $1,717,000 | -10.9% | 381,531 | -11.1% | 0.00% | – |
| Q1 2016 | $1,927,000 | -18.4% | 429,126 | -4.4% | 0.00% | – |
| Q4 2015 | $2,361,000 | -11.2% | 448,861 | -2.6% | 0.00% | – |
| Q3 2015 | $2,660,000 | -19.8% | 460,992 | -0.6% | 0.00% | -100.0% |
| Q2 2015 | $3,315,000 | +10.8% | 463,704 | +3.2% | 0.00% | – |
| Q1 2015 | $2,993,000 | +8.4% | 449,408 | -2.7% | 0.00% | – |
| Q4 2014 | $2,762,000 | +16.9% | 461,826 | -3.4% | 0.00% | – |
| Q3 2014 | $2,363,000 | +3.5% | 478,262 | -5.8% | 0.00% | – |
| Q2 2014 | $2,284,000 | -2.9% | 507,608 | -2.9% | 0.00% | – |
| Q1 2014 | $2,352,000 | -23.7% | 522,768 | -13.4% | 0.00% | -100.0% |
| Q4 2013 | $3,084,000 | -37.3% | 603,596 | -44.5% | 0.00% | 0.0% |
| Q3 2013 | $4,922,000 | -1.3% | 1,086,628 | +11.3% | 0.00% | 0.0% |
| Q2 2013 | $4,989,000 | – | 976,350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 739,917 | $5,135,000 | 2.89% |
| JW Asset Management, LLC | 263,881 | $1,830,000 | 0.38% |
| BARD ASSOCIATES INC | 442,825 | $3,075,000 | 0.29% |
| Ariel Investments | 1,393,125 | $9,668,000 | 0.11% |
| TFS CAPITAL LLC | 11,499 | $80,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 293,700 | $2,038,000 | 0.02% |
| DELTA ASSET MANAGEMENT LLC/TN | 12,000 | $83,000 | 0.01% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 10,945 | $76,000 | 0.01% |
| EAGLE GLOBAL ADVISORS LLC | 52,767 | $366,000 | 0.01% |
| Spark Investment Management LLC | 22,600 | $156,000 | 0.01% |